Gene augmentation for X-linked retinitis pigmentosa caused by mutations in RPGR.

ABSTRACT: X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene is a severe and early onset form of retinal degeneration, and no treatment is currently available. Recent evidence in two clinically relevant canine models shows that adeno-associated viral (AAV)-mediated RPGR gene transfer to rods and cones can prevent disease onset and rescue photoreceptors at early- and mid-stages of degeneration. There is thus a strong incentive for conducting long-term, preclinical efficacy and safety studies, while concomitantly pursuing the detailed phenotypic characterization of XLRP disease in patients that may benefit from such corrective therapy.

SUBMITTER: Beltran WA 

PROVIDER: S-EPMC4315918 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature